Tian Deqiao, Zheng Tao
Center for Biosecurity Strategy Management, Beijing Institute of Biotechnology, Beijing, P.R. China.
PLoS One. 2014 Jun 30;9(6):e101163. doi: 10.1371/journal.pone.0101163. eCollection 2014.
Biological agents pose a serious threat to human health, economic development, social stability and even national security. The classification of biological agents is a basic requirement for both biosafety and biodefense. We compared and analyzed the Biological Agent Laboratory Biosafety Category list and the defining criteria according to the World Health Organization (WHO), the National Institutes of Health (NIH), the European Union (EU) and China. We also compared and analyzed the Biological Agent Biodefense Category list and the defining criteria according to the Centers for Disease Control and Prevention (CDC) of the United States, the EU and Russia. The results show some inconsistencies among or between the two types of category lists and criteria. We suggest that the classification of biological agents based on laboratory biosafety should reduce the number of inconsistencies and contradictions. Developing countries should also produce lists of biological agents to direct their development of biodefense capabilities.To develop a suitable biological agent list should also strengthen international collaboration and cooperation.
生物制剂对人类健康、经济发展、社会稳定乃至国家安全构成严重威胁。生物制剂的分类是生物安全和生物防御的基本要求。我们根据世界卫生组织(WHO)、美国国立卫生研究院(NIH)、欧盟(EU)和中国,对生物制剂实验室生物安全类别清单及定义标准进行了比较和分析。我们还根据美国疾病控制与预防中心(CDC)、欧盟和俄罗斯,对生物制剂生物防御类别清单及定义标准进行了比较和分析。结果表明,这两类类别清单和标准之间或相互之间存在一些不一致之处。我们建议,基于实验室生物安全的生物制剂分类应减少不一致和矛盾之处。发展中国家也应制定生物制剂清单,以指导其生物防御能力的发展。制定合适的生物制剂清单还应加强国际协作与合作。